{ "data": { "id": "stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F", "url": "https://statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F", "indicator": { "slug": "new-drug-approvals", "name": "New drug approvals", "definition": "Total number of new medicines granted regulatory marketing authorization for the first time." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 248, "value_text": "248个", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "National Healthcare Security Administration", "org_short_name": "NHSA", "org_url": "https://www.nhsa.gov.cn", "org_tier": 1, "document_title": "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升", "document_url": "http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html", "document_type": "press_release", "locator": "试验包括新药临床试验和生物等效性试验", "quote": "国家药监局药审中心副主任杨志敏则表示，2025年，我国共有248个新药通过临床试验获批上市，涵盖了抗肿瘤、内分泌、精神障碍等18个适应症领域。", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "National Healthcare Security Administration. (2025). 国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Via StatOrigin, https://statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F", "bibtex": "@misc{nhsa2025drugnyzg8f,\n author = {{National Healthcare Security Administration}},\n title = {国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F},\n note = {Original source: http://www.nhsa.gov.cn/art/2026/6/23/art\\_14\\_21076.html. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z", "contested_by": [ { "id": "stat_3C1JM05C6TBXGNX9X6NMFFXRET", "url": "https://statorigin.org/stat/stat_3C1JM05C6TBXGNX9X6NMFFXRET", "indicator": { "slug": "new-drug-approvals", "name": "New drug approvals", "definition": "Total number of new medicines granted regulatory marketing authorization for the first time." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 120, "value_text": "120", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "quote": "Excluding traditional Chinese medicines, the NMPA green-lit 120 new drugs, defined as those that obtained a marketing authorization in the country for the first time.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_3C1JM05C6TBXGNX9X6NMFFXRET", "bibtex": "@misc{dia2025drugffxret,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_3C1JM05C6TBXGNX9X6NMFFXRET},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" } ], "related": [ { "id": "stat_3C1JM05C6TBXGNX9X6NMFFXRET", "url": "https://statorigin.org/stat/stat_3C1JM05C6TBXGNX9X6NMFFXRET", "indicator": "New drug approvals", "region": "China", "period": "2025-01-01", "value": 120, "unit": "count", "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "locator": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "published_date": null } } ] }, "meta": { "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.", "license": "https://creativecommons.org/licenses/by/4.0/", "docs": "https://statorigin.org/docs/api", "total": 1 } }